Medicine 1999-01-01

The ubiquitin-proteasome pathway and pathogenesis of human diseases.

A L Schwartz, A Ciechanover

Index: Annu. Rev. Med. 50 , 57-74, (1999)

Full Text: HTML

Abstract

The ubiquitin-proteasome pathway plays a pivotal role in the degradation of short-lived and regulatory proteins important in a variety of basic cellular processes, including regulation of the cell cycle, modulation of cell surface receptors and ion channels, and antigen presentation. The pathway involves an enzymatic cascade through which multiple ubiquitin molecules are covalently attached to the protein substrate, which is then degraded by the 26S proteasome complex. The pathway has been implicated in several forms of malignancy, in the pathogenesis of several genetic diseases (including cystic fibrosis, Angelman's syndrome, and Liddle syndrome), in immune surveillance/viral pathogenesis, and in the pathology of muscle wasting. The molecular mechanisms that underlie these processes are being unraveled at present.


Related Compounds

Related Articles:

Export-deficient monoubiquitinated PEX5 triggers peroxisome removal in SV40 large T antigen-transformed mouse embryonic fibroblasts.

2015-01-01

[Autophagy 11 , 1326-40, (2015)]

Insights into Ubiquitination from the Unique Clamp-like Binding of the RING E3 AO7 to the E2 UbcH5B.

2015-12-18

[J. Biol. Chem. 290 , 30225-39, (2015)]

Stimulation of ATP-dependent proteolysis requires ubiquitin with the COOH-terminal sequence Arg-Gly-Gly.

1981-09-10

[J. Biol. Chem. 256 , 9235-9241, (1981)]

The ubiquitin system for protein degradation.

1992-01-01

[Annu. Rev. Biochem. 61 , 761-807, (1992)]

Structure and functions of the 20S and 26S proteasomes.

1996-01-01

[Annu. Rev. Biochem. 65 , 801, (1996)]

More Articles...